Mr. Ming
Address:
Room3, Factory(3), 1st Floor, Bldg 25 Phase3.1 Wuhan Optics Valley International Biopharmaceutical Enterprise Accelerator, No. 388, Gaoxin 2nd Road East Lake Hi-Tech, Wuhan, Hubei, China
Telephone:
Zip Code:
Fax:
| Please sign in to view contact details |
Account Registered in:
2020
Business Range:
Agriculture & Food, Health & Medicine
Management System Certification:
ISO 9001
Business Type:
Manufacturer/Factory
Company Introduction
Trade Capacity
Production Capacity
Wuhan Easy Diagnosis Biomedicine Co., Ltd, Located in the National Biological Industry Base in Wuhan province, China. We are a leading IVD manufacturer, specializing in development, production and sales of POCT rapid diagnostic reagents and related equipment.
We have a strong and professional R&D team, with 100, 000 grade clean workshop and international leading production lines. All our ...
We have a strong and professional R&D team, with 100, 000 grade clean workshop and international leading production lines. All our ...
Wuhan Easy Diagnosis Biomedicine Co., Ltd, Located in the National Biological Industry Base in Wuhan province, China. We are a leading IVD manufacturer, specializing in development, production and sales of POCT rapid diagnostic reagents and related equipment.
We have a strong and professional R&D team, with 100, 000 grade clean workshop and international leading production lines. All our products line have been gotten ISO13485: 2016, CE certification, and more than 20 parameters of POCT rapid diagnostic products with SFDA registration. Also, we are the first company making bedside, rapid and quantitative detection in whole blood in China. And our products are selling more than 20 countries. Our intelligent management system provides hospital departments at all levels detections including cardiovascular disease, kidney disease, infectious disease, endocrine and metabolic diseases, obstetrics and gynecology, and eugenics, physical examination and other comprehensive solutions.
Our mission is to be the leading enterprise of the comprehensive solution for POCT field of high science and technology, eDiagnosis is looking forward to working with you hand in hand, let the POCT throughout your country, makes rapid diagnosis be possible for your labs, creates beautiful tomorrow for human health.
We have a strong and professional R&D team, with 100, 000 grade clean workshop and international leading production lines. All our products line have been gotten ISO13485: 2016, CE certification, and more than 20 parameters of POCT rapid diagnostic products with SFDA registration. Also, we are the first company making bedside, rapid and quantitative detection in whole blood in China. And our products are selling more than 20 countries. Our intelligent management system provides hospital departments at all levels detections including cardiovascular disease, kidney disease, infectious disease, endocrine and metabolic diseases, obstetrics and gynecology, and eugenics, physical examination and other comprehensive solutions.
Our mission is to be the leading enterprise of the comprehensive solution for POCT field of high science and technology, eDiagnosis is looking forward to working with you hand in hand, let the POCT throughout your country, makes rapid diagnosis be possible for your labs, creates beautiful tomorrow for human health.
International Commercial Terms(Incoterms):
FOB
Terms of Payment:
Money Gram
Average Lead Time:
Peak Season Lead Time: within 15 workdays, Off Season Lead Time: within 15 workdays
Number of Foreign Trading Staff:
4~10 People
Export Year:
2020-05-21
Export Percentage:
21%~30%
Main Markets:
North America, South America, Eastern Europe, Southeast Asia, Africa, Oceania, Mid East, Eastern Asia, Western Europe
Import & Export Mode:
Exportation via agency
Factory Address:
Room3, Factory(3), 1st Floor, Bldg 25 Phase3.1 Wuhan Optics Valley International Biopharmaceutical Enterprise Accelerator, No. 388, Gaoxin 2nd Road East Lake Hi-Tech, Wuhan, Hubei, China
R&D Capacity:
Own Brand(Ediagnosis)
No. of R&D Staff:
Above 50 People
No. of Production Lines:
Above 10
Annual Output Value:
Above US$100 Million